TC Biopharm : Private Placement - Form 8-K

Item 3.02 Unregistered Sales of Equity Securities

On March 12, 2024, TC Biopharm (Holdings) PLC (the "Company") issued 623,750 american depositary shares (the "ADSs") representing 12,475,000 ordinary shares of the Company upon exercise of outstanding warrants resulting in gross cash proceeds to the Company of £986,398 (approximately $1,263,000). The warrants were issued by the Company on August 30, 2023 as previously disclosed on a Report of Foreign Private Issuer filed with the SEC on August 31, 2023. The Company issued the ADSs pursuant to the exemption from the registration requirements of the Securities Act available under Section 4(a)(2).